Skip to main content
Year archive

NEURIZON THERAPEUTICS LIMITED — 2018 filings

All 39 regulatory filings released by NEURIZON THERAPEUTICS LIMITED (NUZ) in 2018, sourced directly from the official regulator.

39 Filings
2018 Period
2018 filings (39)
Filing Released Lang
PharmAust Develops Method for MPL/Analogue Manufacture 2 pages 172.9KB
Regulatory Filings
2018-12-02 English
GMP Tablet Manufacture Commences for Canine Clinical Trials 2 pages 168.6KB
Regulatory Filings
2018-11-12 English
AGM Presentation 10 pages 1.3MB
AGM Information
2018-11-08 English
Results of Annual General Meeting 1 page 141.9KB
Declaration of Voting Results & Voting Rights Announcements
2018-11-08 English
Appendix 4C & Company Update - Sep 2018 7 pages 358.7KB
Interim / Quarterly Report
2018-10-31 English
PharmAust Develops GMP Method for Monepantel Analogues 1
Regulatory Filings
2018-10-28 English
PharmAust Progresses Monepantel Tablet Program for Cancer 1
Regulatory Filings
2018-10-14 English
Notice of Annual General Meeting/Proxy Form 21 pages 617.6KB
AGM Information
2018-10-09 English
Appendix 3X & 3Z 4 pages 216.9KB
Director's Dealing
2018-10-07 English
Neville Bassett AM appointed to PharmAust Board 2 pages 193.8KB
Board/Management Information
2018-10-01 English
Annual Report 57 pages 1.6MB
Annual Report
2018-09-30 English
Appendix 4G & Corporate Governance Statement 21 pages 606.8KB
Governance Information
2018-09-30 English
Olivia Newton-John Cancer Reseach Institute collaboration 2 pages 74.9KB
Regulatory Filings
2018-09-09 English
Reformulation of MPL into tablet form for upcoming trials 1
Regulatory Filings
2018-09-03 English
Preliminary Final Report 12 pages 128.1KB
Annual Report
2018-09-02 English
Appendix 4C & Company Update - June 18 8 pages 420.6KB
Interim / Quarterly Report
2018-07-30 English
Epichem gains prestigious international ISO accreditation 2 pages 75.8KB
Regulatory Filings
2018-07-01 English
Becoming a substantial holder 3 pages 909.3KB
Regulatory Filings
2018-06-28 English
Change of Director's Interest Notice - Bishop 2 pages 39.1KB
Director's Dealing
2018-06-26 English
Change of Director's Interest Notice - Bishop (re-release) 3 pages 45.7KB
Director's Dealing
2018-06-26 English
Change of Director's Interest Notice - Wright 2 pages 41.5KB
Director's Dealing
2018-06-25 English
Epichem Awarded Major US Drug Discovery Contract Extension 1
Capital/Financing Update
2018-06-06 English
MPL successfully reformulated for canine clinical trials 1
Regulatory Filings
2018-05-27 English
Chief Executive Officer resigns 1 page 145.9KB
Board/Management Information
2018-05-20 English
Appendix 4C & Company Update 9 pages 180.7KB
Interim / Quarterly Report
2018-04-30 English
PharmAust enters option to license agreement with Elanco 2 pages 79.1KB
Capital/Financing Update
2018-04-17 English
Trading Halt 2 pages 305.5KB
Regulatory Filings
2018-04-15 English
Wayne Best appointed Epichem Chairman and Dr Keenan as CEO 3 pages 81.9KB
Board/Management Information
2018-04-09 English
Cleansing Notice 1 page 78.6KB
Share Issue/Capital Change
2018-03-19 English
Appendix 3B & s708 notice 14 pages 162.2KB
Share Issue/Capital Change
2018-03-15 English
Change of Director's Interest Notice x 3 7 pages 71.7KB
Director's Dealing
2018-03-15 English
Collaboration with Olivia Newton-John Cancer Research Inst 2 pages 312.7KB
Regulatory Filings
2018-03-13 English
PharmAust receives $354k R&D Tax Incentive Refund 1
Capital/Financing Update
2018-02-27 English
Appendix 4D and Half Yearly Report & Accounts 18 pages 293.1KB
Interim / Quarterly Report
2018-02-27 English
Results of General Meeting 1 page 44.8KB
Declaration of Voting Results & Voting Rights Announcements
2018-02-25 English
Appendix 4C - Quarterly Report & Shareholders Update 9 pages 292.2KB
Interim / Quarterly Report
2018-01-30 English
Monepantel reformulation successfully improves dose & taste 1
Capital/Financing Update
2018-01-29 English
Notice of General Meeting/Proxy Form 18 pages 121.4KB
Proxy Solicitation & Information Statement
2018-01-28 English
Epichem Awarded One Year Contract Extension from DNDi 1
Regulatory Filings
2018-01-17 English